Cheryl Zimberlin

Cheryl Zimberlin, PhD, joined Merck Ventures in May 2016 and is currently an Associate in the Healthcare team. Cheryl received her BSc. Hons. in Biology from the University of Utrecht, a MSc in Biotechnology from the University of Wageningen and a PhD in Oncology from the University of Amsterdam. Before joining Merck Ventures she had a successful academic career publishing in top-tier academic journals, including Nature. Cheryl is based in Amsterdam and is board observer in Inthera Bioscience.